IHC demonstrated that PP2A and its endogenous inhibitors, PP2A inhibitor 2 (I2PP2A/SET) and cancerous inhibitor of PP2A (CIP2A), were present in all three medulloblastoma PDXs (Fig. 1A). Here, CIP2A is linked to medulloblastoma.